SCHEMBL1966248

SCHEMBL1966248

CCOC(=O)c1cc(N)c(N)cc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
HSD17B10 Q99714 4/20 0.54
GAA P10253 3/20 0.49
MAPK1 P28482 1/20 0.49
TSHR P16473 2/20 0.48
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
JMJD6 Q6NYC1 1/20 0.45
KDM4E B2RXH2 5/20 0.44
MAPT P10636 3/20 0.44
LMNA P02545 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2596428 0.91 ALDH1A1 (0.53) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL17930512 0.90 ALDH1A1 (0.51) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL9710977 0.87 ALDH1A1 (0.49) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL1964928 0.84 ALDH1A1 (0.46) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL16647668 0.84 KDM4E (0.47) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL11962196 0.84 ALDH1A1 (0.46) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL3242255 0.83 ALDH1A1 (0.49) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL364335 0.83 TSHR (0.53) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL21723240 0.83 ALDH1A1 (0.51) ALDH1A1HSD17B10GAAMAPK1TSHR
SCHEMBL7471868 0.83 ALDH1A1 (0.63) ALDH1A1HSD17B10GAAMAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8916599-B2 1H-benz imidazole-5-carboxamides as anti-inflammatory agents OREXO AB (SE) 2014-12-23 US disclosed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP disclosed
WO-2010034796-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents MAPRE2, MAPRE1, H1-4 ALDH1A1 1202/4885HSD17B10 4544/4885GAA 2503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.